Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis polyneuropathy as a key example

• Published in: Journal of the peripheral nervous system Vol. 28; no. 1; pp. 79 - 85
• Main Authors: Hens, Dries, Wyers, Lore, Claeys, Kristl G.
• Format: Journal Article
• Language: English
• Published: Malden, USA Wiley Periodicals, Inc 01-03-2023; Wiley Subscription Services, Inc
• Subjects: Algorithms; Amyloid Neuropathies, Familial - diagnosis; Amyloid Neuropathies, Familial - genetics; Amyloidosis; Artificial Intelligence; data mining; Diagnosis; early diagnosis and treatment; Electronic Health Records; Electronic medical records; Genetic screening; hereditary transthyretin amyloidosis polyneuropathy; Humans; Medical records; Medical treatment; natural language processing; Patients; Polyneuropathies - diagnosis; Polyneuropathy; Rare Diseases; Retrospective Studies; Transthyretin; rare diseases; hereditary transthyretin amyloidosis polyneuropathy; natural language processing; early diagnosis and treatment; data mining
• ISSN: 1085-9489; 1529-8027
• DOI: 10.1111/jns.12523

Rare life‐threatening conditions, such as multisystemic hereditary transthyretin amyloidosis (ATTRv) polyneuropathy, are often underdiagnosed or diagnosed late in the disease course, although early diagnosis is crucial for treatment success. Red flag symptoms have been identified, but manual screening of multidisciplinary medical records on this set of symptoms is time‐consuming. This study aimed to validate a Natural Language Processing (NLP) algorithm to perform such a search in an automated manner, in order to improve early diagnosis and treatment. A novel state‐of‐the‐art NLP procedure was applied to extract red flag symptoms from patients' electronic medical records and to select patients at risk for ATTRv polyneuropathy for further clinical review. Accuracy of the algorithm was assessed through comparison with a manual standard on a random sample of 300 patients. Out of a retrospective sample of 1015 patients, the NLP algorithm yielded 128 patients with three or more red flag symptoms of which 69 patients were considered eligible for genetic testing after clinical review. High accuracy was found in the detection of red flag symptoms, with F1 scores between 0.88 and 0.98. A relative increase of 48.6% in genetic testing, to identify patients with a rare disease earlier, was demonstrated. An NLP algorithm, after clinical validation, offers a valid and accurate tool to detect red flag symptoms in medical records across multiple disciplines, supporting better screening for patients with rare diseases. This opens the door to further NLP applications, facilitating rapid diagnosis and early treatment of rare diseases.